Demographics
|
|
|
|
Age, mean (SD)
|
15.48 (1.99)
|
13.74 (1.36)
|
<.0001
|
Female, N (%)
|
74 (60%)
|
41 (51%)
|
0.2682
|
Country
|
|
|
|
Israel, N (%)
|
97 (78%)
|
80 (100%)
|
<.0001
|
Slovenia, N (%)
|
27 (22%)
|
|
|
Disease duration, mean (SD)
|
4.12 (3.79)
|
|
|
AIIRD, N (%)
|
124 (100%)
|
|
|
JIA, N (%)
|
54 (44%)
|
|
|
SLE, N (%)
|
20 (16%)
|
|
|
Autoinflammatory diseases, N (%)
|
11 (9%)
|
|
|
Scleroderma, N (%)
|
7 (6%)
|
|
|
Vasculitis, N (%)
|
6 (5%)
|
|
|
Uveitis, N (%)
|
8 (6%)
|
|
|
Myositis, N (%)
|
5 (4%)
|
|
|
IBD related arthritis, N (%)
|
7 (6%)
|
|
|
Other, N (%)
|
6 (5%)
|
|
|
Immunosuppressive treatment, N (%)
|
92 (74%)
|
|
|
Methotrexate treatment, N (%)
|
27 (22%)
|
|
|
Biologic treatment, N (%)
|
48 (39%)
|
|
|